INTRODUCTION
============

Chagas disease (CD) is a vector borne disease caused by *Trypanosoma cruzi* (*T. cruzi*). The clinical course of Chagas disease is usually divided into an acute phase and a chronic phase. The acute phase immediately follows infection. In the past, the disease was transmitted mostly by infected feces deposited during the vector blood meal. In addition to vector-borne transmission, *T. cruzi* may be transmitted through blood transfusion, organ solid and stem cels transplantation. In spite of advances in vector and transfusion control programs especially from Intergovernmental initiatives triggered in the 1990s. Chagas disease still remains an important public health problem due to congenital transmission and ingestion of contaminated food[@B1]. Acute Chagas disease (ACD) is characterized by an acute febrile syndrome associated with nonspecific signs and symptoms similar to other tropical diseases such as malaria, visceral leishmaniasis and typhoid fever[@B2]. If undetected and untreated, its mortality can reach 10% of the cases[@B3]. Chagas disease (CD) is a neglected disease and the measures necessary for its prevention, diagnosis and treatment are far from ideal. Its prevalence is unclear due to underreporting and the spatial heterogeneity of the zoonotic cycle[@B4]. In Brazil, most ACD cases occur in the Amazon Region whose vast area, with immense biodiversity, limits surveillance and vector control. Besides, the access to health services is precarious. In this region, the main source of infection is the oral ingestion of contaminated food, such as *açaí* (*Euterpe oleracea*) or bacaba palm fruit (*Oenocarpus bacaba*). Recently, an increase in the number of cases has been recorded despite the initiatives of artisanal products quality control[@B5]. Detection of acute phase infections is relatively uncommon due to the nonspecific clinical symptoms observed in most infected patients. Frequently, only the more severely affected patients are diagnosed in this phase[@B6]. Direct examination of stained thick blood smears are widely used in the Brazilian Amazon region due to the practicality, low cost and availability[@B7]. Currently, access to PCR for detection of acute phase infections or reactivations is limited and, in general, not available in the areas where oral transmission is more frequent. The Faculdade de Medicina of the Universidade de Sao Paulo, SP, maintain in the city of Santarem, Para State, Brazil, the Nucleus of Tropical Medicine (NUMETROP), with a small team of medical doctors specialized in tropical diseases.

We report an ACD case that occurred in the municipality of Santarem, Para State, Brazil, in a 22 months-old infant, after the oral ingestion of bacaba palm fruit\'s wine. Correct but late diagnosis and treatment were insufficient to save her life, indicating the need for better management and methods that could help clinicians. Another eight cases of ACD were diagnosed in the same riverside community.

CASE REPORT
===========

NUMETROP infectious physicians of the Hospital Municipal de Santarem admitted a 22 female months-old infant, in April 2016, in a fair general condition, with bipalpebral edema and anasarca. She was from the Riverside community of Marimarituba, municipality of Santarem, Para State, far from Santarem downtown eight hours by boat. The parents refered she has had fever, vomiting, diarrhea and upper abdominal pain thirteen days before the hospital admission ([Figure 1](#f1){ref-type="fig"}). Homogeneous central rash, heart rate of 112 bpm and liver at 2 cm below the costal margin were observed in the physical examination.

![Evolution of the patient from the ingestion of "bacaba palm fruit\'s wine" until the fatal outcome.](1678-9946-rimtsp-61-S1678-9946201961027-gf01){#f1}

Admission exams results: Hemoglobin 10.2 g/dL, hematocrit 28.4%, 7,800 leukocytes/mm^3^, 4,602 lymphocytes/mm^3^, platelets 102,000/mm^3^, positive blood smear with visualization of *T. cruzi* trypomastigotes. When asked, the parents reported that twenty-three days before hospitalization, the child had ingested the "bacaba palm fruit\'s wine", corresponding to Day 0 in [Figure 1](#f1){ref-type="fig"}. She was the first patient detected in an outbreak with more eight infected individuals detected. Additional exams showed AST 83 U/L, ALT 55 U/L. Normal Chest X-ray. Electrocardiogram: inversion of the T wave in V1-V3. On day 24, treatment was initiated with orally administrated Benznidazole (10 mg/kg/day, three times a day), and no side effects were noticed. She was discharged asymptomatic with negative blood smear on day 10 of Benznidazole, due to social reasons.

Her parents were oriented to return if there was worsening of the clinical picture. A 60-day treatment was prescribed, but the patient suddenly died three days later ([Figure 1](#f1){ref-type="fig"}). Necropsy was not available. The indirect immunofluorescence (IF) tests, which were performed in the LACEN (Central Laboratory of Public Health of Para), were positive for anti-*T.cruzi* IgG antibodies (titer 1/160) and for IgM antibodies (titer 1/80).

Other specific tests for the diagnosis of ACD were collected after 5 days of Benznidazole and carried out in a research laboratory at the Faculdade de Medicina of the Universidade de Sao Paulo, that supports NUMETROP, after the the parents\' authorization. The study was approved by the Research Ethics Committee of Faculdade de Medicina of the Universidade de Sao Paulo, process N° 2695.519.

The Laboratory of Medical Research in Immunology of the Hospital das Clinicas of the Universidade de Sao Paulo, that supports NUMETROP, carried out in house molecular tests.

Quantitative PCR
----------------

Quantitative PCR (qPCR) for *T. cruzi* detection was performed following previously described methodology[@B8]. *T. cruzi* was typed using two different parasite genomic sequences.

24Sα ribosomal (rRNA) gene D7 domain
------------------------------------

The hemi-nested PCR was performed as previously described[@B9] with modifications: D75 and D76 primers were used in first round and D71 and D72 primers were used in the second round. Amplifications were performed in a GenePro Thermal Cycler (Hangzhou Bioer Technology Co., Ltd., China), as follows: first round, touchdown hold (95 °C for 3 min); 6 cycles (94 °C for 60 s; 64 °C for 60 s; 72 °C for 60 s; reducing the annealing temperature by 2 °C each 2 cycles); 29 cycles (94 °C for 60 s; 58 °C for 60\'s; 72 °C for 60 s). The second round parameters were: 94 °C for 3 min; 3 cycles (94 °C for 30 s, 60 °C for 30 s, 72 °C for 30 s); 3 cycles (94 °C for 30 s, 57 °C for 30 s, 72 °C for 30 s); 20 cycles (94 °C for 30 s, 55 °C for 30 s, 72 °C for 30 s). Amplicons of 110-bp are characteristic of TcI/TcIII DTU; 125-bp of TcII/TcVI; 110+125-bp of TcV and 120 or 130 of TcVI.

Spliced leader genes intergenic region (mini-exon gene)
-------------------------------------------------------

DNA was amplified according to the previously described multiplex protocol[@B10]: Three oligonucleotides, derived from a hypervariable region of the *T. cruzi* mini-exon repeat and an oligonucleotide from a specific region of the *T. rangeli* nontranscribed spacer were used as upstream primers. A common oligonucleotide, designed in the most conserved part of the miniexon, was used as the downstream primer. Amplicons of 150-bp are characteristic of TcIII/TcIV DTU; 200-bp of TcI and 250-bp of TcII; TcV as well as TcVI and *T. rangeli* generated an amplicon of 100pb.

Amplified products were visualized by means of a capillary gel electrophoresis apparatus (GelBot, Loccus Biotecnologia, Brazil). A high resolution cartridge S1 kit was applied (Loccus Biotecnologia, Brazil) and data were analyzed by means of the software Q-Analyzer.

*Trypanosoma cruzi*, and *Trypanosoma rangeli* reference strains were used as markers of the six DTUs ([Table 1](#t1){ref-type="table"}).

###### Description of *Trypanosoma cruzi* and *Trypanosoma rangeli* reference strains used in this study and the respective gene sequences GenBank accession numbers.

  Species        DTU         Sample ID        Host species        GeneBank accession number                
  -------------- ----------- ---------------- ------------------- --------------------------- ------------ ----------
  *T*. *cruzi*   TcI         JR cl4           *H. sapiens*                                    HQ604893.1   
  TcII           Y           *H. sapiens*     AF301912                                                     
  TcIII          MT3663      *H. sapiens*     AF303060                                                     
  TcIV           JJ          *H. sapiens*     AY491761                                                     
  TcV            Bertha      *H. sapiens*     FJ555614                                                     
  TcVI           CL Brener   *T. infestans*   AF245383                                                     
  *T. rangeli*               Tra1719          *A. planirostris*                                            JF421351

DISCUSSION
==========

In this case report, it is important to highlight the variables that may have influenced the fatal outcome. Death among young people is described in ACD outbreaks[@B11] ^--^ [@B13]. Beyond the young age, her remarkable symptomatology, characterized by the presence of multiple clinical manifestations, compatible with the simultaneous involvement of several organs and systems, could be related to the fatality. This child presented fever, tachycardia, gastrointestinal manifestations (vomiting, diarrhea, hepatomegaly and upper abdominal pain), skin rash, anasarca whereas ACD is usually oligosymptomatic or asymptomatic[@B2]. Oral transmission of *T. cruzi* has been associated with more severe clinical outcome[@B14] when the usual cause of death is frequently an acute myocarditis. However, fatal evolution due to stroke and upper gastrointestinal bleeding has also been described. Treatment was not initiated until 15 days after the beginning of the clinical manifestations. This delay may have contributed to the slower therapeutic response, given the extent of the illness[@B15].

In addition, her laboratorial parameters showed low platelets and altered liver enzymes in parallel with the very high parasitemia. Taken together, all these factors contributed to the fatal evolution[@B16]. In the fatal case reported herein, the parasite load was extremely high (54,053.42 parasite equivalents/mL) by qPCR; this result is corroborated by a clinical study in which parasitic loads in ACD samples were higher than in chronic CD cases, reaching concentrations of up to 8 Log~10~ parasite equivalents/10 mL[@B17]. However, parasites were not detected by blood smear examination performed on the seventh day of Benznidazole treatment.

The genetic diversity of the parasite can probably have influenced the natural history of the disease, the diagnosis and the treatment of ACD[@B18]. *T. cruzi* specific DTU TcIVwas observed and is shown in [Figures 2A](#f2){ref-type="fig"} and [2B](#f2){ref-type="fig"}. In the Amazon Basin, DTU TcI and IV are the usual *T. cruzi* DTUs found in isolates[@B19]. In experimental studies, TcIV showed higher virulence and fatality rate in shorter periods of time when compared to TcI[@B20]. The different behaviors of each DTU can possibly be associated with the severity of infections, and it is possible that in humans, TcIV may also be more virulent and associated with the fatal evolution observed in this child.

![Representative electrophoretic pattern of 24Sα region of *T. cruzi*. A) Lanes I-VI: reference strains TcI (JR cl4), 110 bp; TcII (Y), 125 bp; TcIII (MT3663), 110 bp; TcIV (JJ), 120 bp; TcV (Bertha), 125 and 110 bp and TcVI (CL-Brener), 125 bp; Lane S, pattern of the 120-bp amplication product from the 24Sα region from a human blood sample; B) The eletropherogram shows the relative fluorescent unit (RFU) of the amplified fragment: 24Sα of the reference strain TcIV (JJ) and the pattern of 24Sα region (120 bp) amplification product from a human blood sample.](1678-9946-rimtsp-61-S1678-9946201961027-gf02){#f2}

Nevertheless, the frequency of T. cruzi DTUs during outbreaks in the Amazon region is currently unknown. As a large amount of *T. cruzi* DNA is required for the DTU typing, methods such as hemoculture and xenodiagnosis are often used to increase the number of available parasites before DTU typing, which may select a faster multiplying DTU, masking the DTU typing result. In this study, the DTU typing was directly performed from the patient\'s blood, eliminating this "masking effect".

In a retrospective study carried out from 2009 to 2013, it was shown that the number of cases and the lethality of ACD represents a serious public health problem in Brazil[@B12] and from an economical point of view it is worth paying attention and investing on fighting Chagas disease. It is also important that research laboratories contribute to the diagnosis and to increase information on the parasite complexity, which can potentially improve the quality of medical care, avoiding outcomes as unfavorable as the one described in this report.
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